IL-2 R beta/CD122 hFc Chimera, Human
IL-2 R Beta/CD122 HFc Chimera, Human

Immobilized IL-2 R beta/CD122 hFc Chimera, Human, hFc Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human IL-15RA&IL-15, His Tag with the EC50 of 22.9ng/ml determined by ELISA.

IL-2 R Beta/CD122 HFc Chimera, Human

The purity of IL-2 R beta/CD122 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

IL-2 R Beta/CD122 HFc Chimera, Human

IL-2 R beta/CD122 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

IL-2 R beta/CD122 hFc Chimera, Human

IL-2 R beta is a member of the cytokine receptor superfamily. Human IL-2 R beta cDNA encodes a 551 amino acid residue precursor Type I membrane protein with a 26 residue signal peptide, a 214 residue extracellular region, a 25 residue transmembrane region and a 286 residue cytoplasmic domain. Functional IL-2 receptors can exist in two affinity states on cell surfaces, the high affinity complex consisting of heterotrimers of the alpha, beta, and gamma chains, and the intermediate affinity complex comprising heterodimers of the beta and gamma chains.
Z04274
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
IL-2 R beta/CD122 (Ala27-Asp239)
Accession # NP_000869		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 51.35 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • IL-2 R Beta/CD122 HFc Chimera, Human
    • IL-2 R Beta/CD122 HFc Chimera, Human

    Immobilized IL-2 R beta/CD122 hFc Chimera, Human, hFc Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human IL-15RA&IL-15, His Tag with the EC50 of 22.9ng/ml determined by ELISA.

  • IL-2 R Beta/CD122 HFc Chimera, Human
    • IL-2 R Beta/CD122 HFc Chimera, Human

    The purity of IL-2 R beta/CD122 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

  • IL-2 R Beta/CD122 HFc Chimera, Human
    • IL-2 R Beta/CD122 HFc Chimera, Human

    IL-2 R beta/CD122 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background IL-2 R beta is a member of the cytokine receptor superfamily. Human IL-2 R beta cDNA encodes a 551 amino acid residue precursor Type I membrane protein with a 26 residue signal peptide, a 214 residue extracellular region, a 25 residue transmembrane region and a 286 residue cytoplasmic domain. Functional IL-2 receptors can exist in two affinity states on cell surfaces, the high affinity complex consisting of heterotrimers of the alpha, beta, and gamma chains, and the intermediate affinity complex comprising heterodimers of the beta and gamma chains.
Synonyms CD122; IL-15 R beta; IL-2 R beta; IL-2R subunit beta; IL2RB; P70-75; p75; RP5-1170K4.6; IL-15 R β; IL-2 R β; IL-2R subunit β

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.